NeoGenomics, Inc. Total Assets
NeoGenomics, Inc. (NEO) had Total Assets of $1.35 billion as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-28
- 2026-06-30: Assets $1.35B.
- 2026-03-31: Assets $1.35B.
- 2025-12-31: Assets $1.36B.
- 2025-09-30: Assets $1.37B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $1.35B 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $1.35B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $1.36B 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $1.37B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.39B 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $1.60B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.64B 10-K · filed 2026-02-17 | |
| 2024-09-30 | $1.64B 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $1.64B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.64B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $1.68B 10-K · filed 2025-02-18 | |
| 2023-09-30 | $1.68B 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $1.70B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.71B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.74B 10-K · filed 2024-02-20 | |
| 2022-09-30 | $1.76B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.79B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.83B 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.87B 10-K · filed 2023-02-24 | |
| 2021-09-30 | $1.91B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.90B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.49B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $988.33M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $959.43M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $945.49M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $732.25M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $709.51M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $711.15M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $696.67M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $533.34M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $505.01M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $455.14M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $345.78M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $349.27M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $344.45M 10-K · filed 2019-02-26 | $343.34M 10-K · filed 2018-03-13 |
| 2017-09-30 | $343.89M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $339.88M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $343.64M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $337.12M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $355.43M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $351.56M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $346.84M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $351.29M 10-K · filed 2017-03-14 | $367.95M 10-K · filed 2016-03-15 |
| 2015-09-30 | $83.74M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $82.97M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $81.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $81.11M 10-K · filed 2016-04-18 | |
| 2014-09-30 | $78.82M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $43.64M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $42.32M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $39.92M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $35.23M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $34.46M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $33.62M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $30.07M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $29.30M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $28.00M 10-Q/A · filed 2012-08-15 | |
| 2012-03-31 | $26.44M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $19.95M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $17.48M 10-Q · filed 2011-10-25 | |
| 2011-06-30 | $16.66M 10-Q/A · filed 2011-08-01 | |
| 2010-12-31 | $13.65M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |